Skip to content
healthcare.dev
Get a free key

Augtyro

NDC 0003-4160, repotrectinib, capsule, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-4160
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218213
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-4160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPOTRECTINIB160 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inducers [MoA]; Kinase Inhibitor [EPC]; Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]; Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA]; Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA]; Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]

Package NDCNDC-11Package
0003-4160-140000341601414 CAPSULE in 1 BOTTLE (0003-4160-14)
0003-4160-600000341606060 CAPSULE in 1 BOTTLE (0003-4160-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fb526827-40ba-4462-94cf-179ae3b0cb8a

Use it

Look up 0003-4160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-4160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-4160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.